A peer-reviewed study published in The Journal of Neuroimmune Pharmacology points to the potential efficacy of using cannabidiol (CBD) as a treatment for multiple sclerosis (MS) and related diseases. Several researchers at Tel Aviv University conducted the study. From the Huffington Post:
"Inflammation is part of the body's natural immune response, but in cases like MS it gets out of hand," Dr. Kozela explained. "Our study looks at how compounds isolated from marijuana can be used to regulate inflammation to protect the nervous system and its functions."
The study's researchers determined that the manifestation of CBD or THC confines the immune cells from prompting the production of inflammatory molecules and in turn limits the molecules' capacity to reach and damage the spinal cord and/or brain.
Read the full article at the Huffington Post.